Medicamen Biotech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 38.92 | 31.21 | 41.28 |
Operating Expense | 34.41 | 27.09 | 34.90 |
Net Profit | 1.64 | 2.40 | 2.52 |
Net Profit Margin | 4.21 | 7.69 | 6.10 |
Earning Per Share | 1.21 | 1.90 | 1.98 |
EBIDTA | 4.54 | 4.23 | 6.45 |
Effective Tax Rate | 12.67 | 17.68 | 16.14 |
Particulars | Jun 2025 |
---|---|
Revenue | 38.92 |
Operating Expense | 34.41 |
Net Profit | 1.64 |
Net Profit Margin | 4.21 |
Earning Per Share | 1.21 |
EBIDTA | 4.54 |
Effective Tax Rate | 12.67 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 151.46 | 172.39 | 137.88 |
Operating Expenses Annual | 134.91 | 146.42 | 113.74 |
Operating Profit Annual | 22.78 | 28.27 | 26.61 |
Interest Annual | 3.05 | 4.38 | 2.92 |
Depreciation | 6.81 | 6.83 | 6.24 |
Net Profit Annual | 9.45 | 13.30 | 15.00 |
Tax Annual | 3.33 | 3.59 | 2.33 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 151.46 |
Operating Expenses Annual | 134.91 |
Operating Profit Annual | 22.78 |
Interest Annual | 3.05 |
Depreciation | 6.81 |
Net Profit Annual | 9.45 |
Tax Annual | 3.33 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 14.62 | 20.44 | 3.81 |
Cash Flow from Operations | -2.63 | -0.25 | -3.50 |
Cash Flow from Investing | -1.72 | -8.71 | -7.54 |
Cash Flow from Financing | -6.68 | 3.14 | 27.67 |
Cash Flow at the End | 3.58 | 14.62 | 20.44 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 14.62 |
Cash Flow from Operations | -2.63 |
Cash Flow from Investing | -1.72 |
Cash Flow from Financing | -6.68 |
Cash Flow at the End | 3.58 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 15.41 | 17.14 | 19.64 |
PBIT Margin (%) | 10.81 | 13.08 | 15.03 |
PBT Margin (%) | 7.81 | 10.77 | 10.60 |
Net PROFIT Margin (%) | 6.24 | 7.72 | 10.88 |
Return On Networth / Equity (%) | 4.43 | 6.60 | 8.78 |
Return On Networth /Employed (%) | 6.71 | 9.76 | 10.45 |
Return On Assets (%) | 3.87 | 5.79 | 7.62 |
Total Debt / Equity (X) | 0.13 | 0.14 | 0.15 |
Asset Turnover Ratio (%) | 0.62 | 0.75 | 0.70 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 15.41 |
PBIT Margin (%) | 10.81 |
PBT Margin (%) | 7.81 |
Net PROFIT Margin (%) | 6.24 |
Return On Networth / Equity (%) | 4.43 |
Return On Networth /Employed (%) | 6.71 |
Return On Assets (%) | 3.87 |
Total Debt / Equity (X) | 0.13 |
Asset Turnover Ratio (%) | 0.62 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 86.31 | 91.10 | 92.36 |
Total Current Assets Annual | 153.51 | 152.37 | 157.97 |
Non Current Assets Annual | 139.68 | 141.84 | 118.81 |
Total Shareholders Funds Annual | 217.64 | 209.21 | 193.80 |
Total Assets Annual | 293.19 | 294.21 | 276.78 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 86.31 |
Total Current Assets Annual | 153.51 |
Non Current Assets Annual | 139.68 |
Total Shareholders Funds Annual | 217.64 |
Total Assets Annual | 293.19 |
EPS (INR)
Expected
1.59
Reported
1.18
Surprise
-25.79%
Mar 2025
EPS beaten by -25.79%
Dec 2024
EPS beaten by -22.22%
Sep 2024
EPS beaten by -15.75%